NCT02622503已完成不适用
Retrospective Data Collection on Rheumatoid Arthritis (RA) Patients Treated With Rituximab in Finland.
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 81
- 主要终点
- Information on previous RA treatments
研究概览
简要总结
The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Rheumatoid arthritis (RA) patients treated with rituximab in Finland
排除标准
- •Not applicable
研究组 & 干预措施
Patients with rheumatoid arthritis
Patients with rheumatoid arthritis receiving rituximab will be observed for treatment responses.
干预措施: Rituximab (Drug)
结局指标
主要结局
Information on previous RA treatments
时间窗: 3 months
Information on rituximab treatment responses
时间窗: 3 months
Information on concomitant medications
时间窗: 3 months
次要结局
未报告次要终点
研究者
相似试验
已完成
3 期
Rituximab in Rheumatoid Arthritis Lung DiseaseRheumatoid ArthritisInterstitial PneumoniaNCT00578565Eric Matteson10
已完成
不适用
Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in SpainRheumatoid ArthritisNCT00881881Wyeth is now a wholly owned subsidiary of Pfizer360
已完成
不适用
Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)Rheumatoid ArthritisNCT00724243Merck Sharp & Dohme LLC33
已完成
不适用
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic TreatmentRheumatoid ArthritisNCT00929357Pfizer156
撤回
不适用
Rheumatoid Arthritis and Myositis CohortRheumatoid ArthritisMyositisNCT05627089Attune Health Research, Inc.